Clinical study
STAMP
| Status | Recruiting |
|---|---|
| Type | Trial |
| Countries | Australia |
| Study years | 2022–2027 (estimated) |
| Entry review | 2026-10-03 |
Participation
Treating Australian-registered infectious-diseases specialist referral through Phage Australia; suitable clinical and phage/regulatory requirements apply.
Check the study record or contact the study team for current recruitment and eligibility.
Study description
Standardized monitoring of personalized phage treatment; adults and children in an Australian multisite network.
Study registrations
| ANZCTR | ACTRN12621001526864 |
|---|
Related programs(3)
Phage Australia
Case-by-case; Official referral/inquiry route
Recorded program–study link. Website
VICPhage Service, The Alfred
Official referral/inquiry route
Recorded program–study link. Website
Westmead Hospital / Westmead Institute for Medical Research phage team
Official referral/inquiry route
Recorded program–study link. Website
Notes from the source review
- Registry protocol recruitment and SAS treatment access coexist; no routine phage product approval or international referral entitlement inferred.
- Source reports accrued participants: 42; target is separate.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Study ID | actrn12621001526864 |
|---|